Novartis to Acquire Avidity Biosciences for US$12 Billion Novartis will acquire Avidity Biosciences for US$12 billion, expanding its genetic medicine pipeline with Avidity's RNA-based ther…
Canadian Lobbyists Represent Both Polluters and Environmental Groups A recent report by FMinus reveals a conflict of interest in Canada's …
EU Enhances Circular Economy Efforts The European Union is taking steps towards a more circular and sustainable economy through the revise…
Building the Future, Respecting the Past Tbilisi is undergoing a dynamic period of transformation, with sustainable urban development taki…
Cygnet Energy to Acquire Kiwetinohk Privately held Cygnet Energy will acquire Kiwetinohk Energy in an all-cash deal valued at C$1.4 billio…
Cultivated Chicken by PARIMA Gains Regulatory Approval PARIMA, a French cultivated meat company, has received regulatory approval for its …
Cultivated Chicken by PARIMA Gains Regulatory Approval PARIMA, a French cultivated meat company, has received regulatory approval for its …
Ecolab Q3 Earnings Report Ecolab reported third-quarter earnings of $585 million, with net income of $2.05 per share. Earnings, adj…
Anchor Tenants Disrupt Manhattan's Office Market Top corporate names are signing for new space years in advance, freeing up much-needed sq…
Cameco and Brookfield Involved in $80 Billion U.S. Nuclear Reactor Deal A deal worth $80 billion has been agreed upon between the governme…
Repligen: Q3 Earnings Snapshot Repligen (RGEN) reported third-quarter net income of $14.9 million, with a profit of 26 cents per share.